Vimarsana
Biggest News Aggregation in the World

Page 14 - Existing Shareholders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Existing Shareholders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Existing Shareholders Today - Breaking & Trending Today

Mister Spex will im dritten Quartal an die Börse - Vimarsana News

Mister Spex will im dritten Quartal an die Börse

Mister Spex will im dritten Quartal an die Börse Der Berliner Optiker will in den kommenden Wochen an die Börse. Dabei werden sowohl neue Aktien als auch Anteile von Altaktionären angeboten. Die Emission soll mindestens 225 Mill. Euro erlösen. Frankfurt, 14.06.2021 © Bildquelle: Mister Spex Der Berliner Online-Optiker Mister Spex will bis Ende September an die Frankfu...

DLP Resources Announces Non-Brokered Private Placement to be Made - Vimarsana News

DLP Resources Announces Non-Brokered Private Placement to be Made

Article content Share“) of the Company and one common share purchase warrant (a “ Warrant“). Each Warrant will entitle the holder to purchase one additional Share of the Company at a price of $0.40 per Share for a period of twelve (12) months from the date of closing. The Warrants are subject to an acceleration clause in the event the trading price of the Shares equals or exceeds $0.50 per Share for a period of ten (10) consecutive days. The Company intends to pay finder’s fees in connection with the Private Placement to certain eligible finders in the form of: (i) a cash commission o...

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases - Vimarsana News

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases News provided by Share this article Share this article SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its Series B financing round which was led by Quan Capital, and followed by a promin...

Investegate |Maven Inc &Grwth VCT Announcements | Maven Inc &Grwth VCT: Statement re Offer for Subscription - Vimarsana News

Investegate |Maven Inc &Grwth VCT Announcements | Maven Inc &Grwth VCT: Statement re Offer for Subscription

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...